COVID-19 detection kit 11NCO50

SARS-COV-2SARS-Cov-2 omicronnasopharyngeal

The continued spread of the SARS-CoV-2 has led to various variants and the B.1.1.529 variant first found in South Africa on November 26, 2021 was named as Omicron by the WHO and classified as a VOC (variant of concern) since its spread and severity were verified to be high. In the case of the existing SARS-CoV-2 PCR test, depending on the target detection gene area, it cannot detect nor distinguish the Omicron variant. Therefore, a PCR test enabling to detect and distinguish the Omicron variant has been required to stop the spread of the variant and prevent its infection through vaccines. STANDARD M SARS-CoV-2/Variant I Real-Time Detection Kit is a real-time RT-PCR assay intended for the in vitro qualitative detection and differentiation of SARS-CoV-2 RNA and the Omicron variant in human nasopharyngeal swab specimens. Intented Use Multiplex real-time RT-PCR test for the qualitative detection of nucleic acid from the SARS-CoV-2/Varient in upper respiratory specimens collected from individuals suspected of COVID-19. Advantage Wild type-Omicron variant detection and differenciation Endogenous internal control One-Step, One-Tube RT-PCR assay High analytical sensitivity Contamination prevention system Specification Analytical sensitivity (LoD) ORF1ab (RdRp) gene = 1.0 copies/㎕, N gene = 1.0 copies/㎕, S_ins214 = 2.0 copies/㎕, S_E484A = 2.0 copies/㎕ Compatible system CFX96 Storage temperature -25~-15℃ (-13~5 °F)